Sage Therapeutics (SG7.F) Q4 2024 Earnings

Oct 29Confirmed
Q2 2024
Q1 2024
Q3 2024
Q4 2024
-1.68
-1.59
-1.5
-1.41

Details

Expected EPS
-1.43691272487
Actual EPS
-1.4140413
Surprise EPS
0.02
Surprise Percent
+1.59%

Description

⁨Sage Therapeutics⁩ (⁦SG7.F⁩) has reported earnings of ⁦-1.4140413⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts